You are here

Drug Forecast

Exenatide (Byetta), an Incretin Mimetic: The First in a New Therapeutic Class in the Treatment of Diabetes

Sweta Chawla, PharmD
PDF version: 
The authors review exenatide (Byetta) for treating diabetes.